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I-46 Clinical management of severe respiratory
infections in adult hospitalized patients
N.L.S. Lee*. Division of Infectious Diseases, Department
of Medicine and Therapeutics, Faculty of Medicine, The
Chinese University of Hong Kong, China
Inﬂuenza is estimated to be responsible for more than
226,000 excess hospital admissions annually in the United
States. Sixty-three percent of all these hospital admissions
occur among persons aged over 65 years, and the numbers
of these hospitalizations have increased over the past
decade. The risks for complications and death from inﬂuenza
are highest among persons at the extremes of age and
those with co-morbidities. In Hong Kong, the disease
burden of inﬂuenza is substantial, and the associated
mortality comparable to the Western countries. It has been
estimated that up to 60 per 10,000 elderly individuals are
hospitalized annually for inﬂuenza-associated complications
such as pneumonia, exacerbation of COPD or asthma, and
acute cardiovascular events. With an aging population,
this creates a heavy burden on the healthcare system.
In the ﬁrst part of this lecture, clinical research on
severe inﬂuenza infection conducted in the hospital setting
will be discussed. Our studies show that inﬂuenza can
result in serious complications, prolonged duration of
hospitalization, and death. Timely diagnosis of inﬂuenza
and initiation of antiviral treatment in the high-risk
patients have signiﬁcantly reduced their duration of
hospitalization (by 33%) and mortality (odds ratio 0.26).
Since ‘cytokine storm’ (e.g. IL-6, IL-8, IP-10 and MIG;
mediated through signaling molecules such as p38 MAPK)
is detected in these patients, and is triggered off by
uncontrolled viral replication, early effective antiviral
treatment may attenuate these deleterious responses, thus
reducing patients’ symptoms. In contrast to previously
healthy subjects, these high-risk patients (mostly have
signiﬁcant comorbid illnesses) have persistently active viral
replication and high viral loads beyond the ﬁrst 2 days
of illness; therefore, a slightly extended time window for
antiviral treatment may be possible. Also, more stringent
infection control measures may be necessary to avoid
nosocomial outbreaks.
In the second part of the lecture, research on the
clinical diagnosis and management of severe community-
acquired pneumonia (CAP) will be presented. Besides usual
bacterial pathogens, respiratory viruses (e.g. inﬂuenza,
RSV, SARS-CoV) and ‘atypical pathogens’ (e.g. mycoplasma,
chlamydophila) are increasingly noted to be important
causes of severe CAP. Utilization of certain clinical
prediction rules to assist decisions on site-of-care (e.g.
PSI, CURB-65), novel diagnostic markers (e.g. procalcitonin,
neopterin), and choice of empirical antibiotic treatment
will also be discussed.
I-47 Creative hand hygiene campaigns
M.L. Ling*. Singapore General Hospital, Singapore
Hand washing is a recognised effective infection control
practice since the time of Semmelweiss. In October
2005, the World Health Organization (WHO) World Alliance
for Patient Safety launched the ﬁrst Global Patient
Safety Challenge 2005 2006, ‘Clean Care is Safer Care’.
This emphasised to the world the key message of
the importance of hand hygiene in reducing healthcare
associated infections. The use of alcohol hand rubs are
recommended to improve compliance amongst healthcare
workers as the time spent in the activity is short and
manageable, in contrast to hand washing. During SARS,
high compliance in healthcare workers to hand hygiene was
primarily driven by fear. However, the post-SARS period
conﬁrmed that this practice was not sustainable.
Campaigns have been known to be a powerful and effective
tool in changing behaviour and culture of a population.
Countries that have used this tool successfully to achieve
higher compliance in hand hygiene at a national level
include USA, UK and Australia. We demonstrate equal level
of effectiveness using the same principles and methodology
at the institutional level.
At the Singapore General Hospital, a 1600-bedded acute
tertiary care hospital, several innovative means are adopted
in its Hand Hygiene campaign since 2003. An objective
validated hand hygiene audit tool in the form of the WHO
tool gave good objective measurement of the baseline and
the progress made during the campaign. Persistent strategic
change was the prime objective of the campaign. Staff
education and prominent cues to action were initial building
blocks used in transforming behaviour. Patient involvement
was engaged in a step-wise manner but its real impact
has yet to be seen as it is still in its early days. The
biggest impact was seen when hand hygiene became a clear
institutional priority in the hospital’s quality and patient
safety arena. Leadership’s support of the campaign through
its visible presence, messaging and release of resources is
the key factor in helping to make the campaign a true
success.
I-48 The clinical characteristics and therapy for SARS
L.M. Guo*. Dept of ICU, Beijing Ditan Hospital, China
Background: 82 patients with SARS were admitted in ICU of
Beijing Ditan Hospital last year. The clinical manifestations
and outcomes of these patients were studied.
Methods: 52 patients in acute stage and 30 patients in
convalescent stage were observed. The examinations of
routine laboratory, chest X-ray and immunocytes were done
in all of patients; the series T-lymphocytes with its subtypes,
the cytokines and RT-PCR for SARS virus were checked in
part of patients; the bacteriological examination was done
in patients with infection at acute or convalescent stage;
the autopsy was performed in 4 died cases.
Results: In acute stage, 10 patients had positive result of
RT-PCR for SARS virus, the time of taking samples was 3
to 16 days after onset. In 2nd week, about 80% patients
had the second peak of fever. As the same time or rather
later, the patients with chest X-ray worsening were 65.4%,
occurring dyspnea were 40.4%, and having ALI were 30.8%.
In 3rd week, the 9 patients had a third peak of fever with
the leukocytosis, their secondary infections were in-hospital
infection. 8 cases were developed ARDS, and 7 cases were
died. The autopsy found that lungs and immune system
were severely damaged. There was a lowest peak of the
lymphocyte and its subtypes at day 8 in mild and general
type group. The lowest peak in severe type group was lower
and later (4 days) than that in mild or general type group. In
extremely severe type group, the lymphocyte subtypes kept
in much lower level very long from day 12 to 28 and didn’t
recover in day 32. TNF-a, IL-6, INF-g, IL-2 and IL-4 were
higher at day 4 6 and then decrease gradually; and IL-10
was higher from the second week. At convalescent stage,
some patients remained interstitial pneumonia or diffuse
pulmonary ﬁbrosis; some patients had pulmonary cavities,
pyothorax or pyohemothorax.
Conclusion: The whole period of SARS could be divided into
four stages: virus replacement stage, inﬂammatory injury
stage, immunodeﬁciency stage and convalescent stage.
The treatments must be applied on the characteristics of
different stages.
